MOLLY OOSTHUYSEN: Open Payments
NPI 1154786937 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 17 payments from 10 companies in 2025. Trend: 2023 $711 · 2024 $1,114 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Grifols USA, LLC | 2 | $41 |
| CSL Behring | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| GENZYME CORPORATION | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Octapharma USA, Inc. | 1 | $20 |
Products named: DUPIXENT, Xembify, Haegarda, FASENRA, NUCALA, NEFFY, Xolair, CUTAQUIG.
Industry payments across TN — which companies pay providers there.
